Last reviewed · How we verify
Cefzil®
At a glance
| Generic name | Cefzil® |
|---|---|
| Sponsor | Teva Pharmaceuticals USA |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Cefprozil 500 mg Tablets Under Fasting Conditions (PHASE1)
- Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting (PHASE1)
- Cefprozil for Oral Suspension 250 mg/5 mL, Fasting (PHASE1)
- Cefprozil 500 mg Tablets Under Fed Conditions (PHASE1)
- Patients Response to Early Switch To Oral:Osteomyelitis Study (EARLY_PHASE1)
- Bioequivalence of Cefprozil Granule in Healthy Chinese Volunteers (PHASE1)
- Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions (NA)
- Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |